Zhejiang Changhai Pharmaceuticals Co Ltd, based in China, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
One of their notable products is LINEZOLID USP (NON-STERILE API), with a corresponding US DMF Number 35938.
Remarkably, this DMF maintains an Active status since its submission on October 15, 2021, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of May 09, 2022, and payment made on January 24, 2022, indicating their dedication to facilitating drug approvals, Categorized as Type II